Left Menu
Development News Edition

Dr Reddy's launches Cinacalcet tablets in US market

The newly launched product is a therapeutic equivalent generic version of Sensipar tablets, approved by the US Food and Drug Administration (USFDA), the Hyderabad-based drug firm said in a regulatory filing. Quoting IQVIA Health data, Dr Reddy's Laboratories said the Sensipar brand and generic market had the US sales of approximately USD 312 million for the most recent twelve months ending July 2020.

PTI | New Delhi | Updated: 01-10-2020 16:48 IST | Created: 01-10-2020 14:59 IST
Dr Reddy's launches Cinacalcet tablets in US market
Image Credit: Wikimedia

Dr Reddy's Laboratories on Thursday said it has launched Cinacalcet tablets, indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis, in the US market. The newly launched product is a therapeutic equivalent generic version of Sensipar tablets, approved by the US Food and Drug Administration (USFDA), the Hyderabad-based drug firm said in a regulatory filing.

Quoting IQVIA Health data, Dr Reddy's Laboratories said the Sensipar brand and generic market had the US sales of approximately USD 312 million for the most recent twelve months ending July 2020. Shares of Dr Reddy's Laboratories were trading 1.25 per cent lower at Rs 5,122 apiece on BSE.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Mizoram, only state which had not reported any COVID-19 fatality so far, registers its first coronavirus death: Health official.

Mizoram, only state which had not reported any COVID-19 fatality so far, registers its first coronavirus death Health official....

The committee was unanimous in its opinion that Twitter's explanation on showing Ladakh as part of China was inadequate: Lekhi told PTI.

The committee was unanimous in its opinion that Twitters explanation on showing Ladakh as part of China was inadequate Lekhi told PTI....

FTSE 100 hits 6-month low on lockdown fears, vaccine uncertainty

Londons FTSE 100 fell to its lowest level in six months on Wednesday as investors took cash off the table on worries of more virus curbs and uncertainty over a coronavirus vaccine, with homebuilders and energy stocks leading the declines. T...

European stocks hit mid-June low on report France mulling national lockdown

European stocks hit their lowest level since mid-June on Wednesday following a report France was mulling a month-long national lockdown to combat a surge in coronavirus infections.The pan-European STOXX 600 index fell 1.6 by 0808 GMT, while...

Give Feedback